News - Unibest Industrial Co., Ltd.

Blogs

Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.

Semaglutide: A Promising Frontier in Alzheimer's Disease Prevention
2024-10-25

We're excited to discuss groundbreaking research on semaglutide, the blockbuster medication that's showing promising potential in the fight against Alzheimer's disease (AD) Read More
Drug Patent & Exclusivity Expiration Report - Week of Oct 21 2024
2024-10-22

This week, there are 3 drugs in the patent and exclusivity list. They are: - BRISTOL-MYERS SQUIBB CO's ABRAXANE, containing active ingredient PACLITAXEL - VERTEX PHARMACEUTICALS INC's TRIKAFTA (COPACKAGED), containing active ingredient ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR - BAUSCH AND LOMB INC's XIPERE, containing active ingredient TRIAMCINOLONE ACETONIDE Read More
Oral SERD Therapy: Elacestrant's Impact on Metastatic Breast Cancer
2024-10-10

IntroductionBreast cancer remains a significant global health challenge, with over 2.3 million new cases diagnosed worldwide in 2022, according to the IARC. The disease burden is disproportionately higher in countries with medium or low levels of the Human Development Index (HDI), where access to in Read More
Drug Briefing: Elacestrant
2024-10-08

Query Drug：ElacestrantQuery Time：2024-10-08 16:20:43*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
Alopecia Areata: More Than Just Hair Loss
2024-09-20

Alopecia areata (AA) is an autoimmune disorder that goes far beyond mere hair loss. While the physical manifestation of patchy or complete hair loss is its most visible symptom, the impact of AA extends deep into the psychological realm, affecting millions worldwide.Understanding Alopecia AreataAlop Read More
Drug Briefing: Ritlecitinib
2024-09-13

Query Drug：RitlecitinibQuery Time：2024-09-13 16:17:58*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
10 Key Considerations for Mastering Active Pharmaceutical Ingredient Procurement: A Unibest Perspective
2024-08-20

At Unibest, we're proud to be the go-to partner for global pharmaceutical companies seeking high-quality active pharmaceutical ingredients (APIs). Our unmatched expertise in sourcing top-tier pharmaceutical ingredients sets us apart. Today, we're sharing our insights on identifying and selecting the Read More
A $25 Billion Opportunity: Exploring the Enormous Market Impact of Deucravacitinib
2024-08-01

Deucravacitinib has emerged as a groundbreaking treatment for moderate-to-severe plaque psoriasis. As we at Unibest keep up with the current pharamceutical blockbusters, we're excited to explore the potential of this novel drug in the enormous oral systemic psoriasis drug market.A Milestone in Deut Read More
5 Benefits of Deuteration in Drug Discovery
2024-07-31

In the recent advancement of pharmaceutical research and development, deuteration has emerged as a powerful tool for enhancing drug properties and creating new opportunities for innovative drug companies. This blog post explores the potential of deuteration and its impact on the pharmaceutical indus Read More